Transcardiac increase in tumor necrosis factor-α and left ventricular end-diastolic volume in patients with dilated cardiomyopathy

European Journal of Heart Failure

Volumn 6, Issue 2, 2004, Pages 173-180

  Tsutamoto, Takayoshi ^a   Wada, Atsuyuki ^a   Ohnishi, Masato ^a   Tsutsui, Takashi ^a   Ishii, Chitose ^a   Ohno, Keijin ^a   Fujii, Masanori ^a   Matsumoto, Takehiro ^a   Yamamoto, Takashi ^a   Takayama, Tomoyuki ^a   Dohke, Tomohiro ^a   Horie, Minoru ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

Brain natriuretic peptide; Dilated cardiomyopathy; Heart failure; Interleukin 6; Tumor necrosis factor ; Ventricular remodeling

Indexed keywords

INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; AORTA ROOT; ARTICLE; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONGESTIVE HEART FAILURE; CORONARY SINUS; CORRELATION ANALYSIS; CYTOKINE RELEASE; EVALUATION; FEMALE; HEART EJECTION FRACTION; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART VENTRICLE REMODELING; HEART VENTRICLE VOLUME; HUMAN; MALE; PRIORITY JOURNAL;

ADULT; AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CARDIOMYOPATHY, DILATED; CASE-CONTROL STUDIES; FEMALE; FUROSEMIDE; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; REGRESSION ANALYSIS; SPIRONOLACTONE; STROKE VOLUME; TUMOR NECROSIS FACTOR-ALPHA; VENTRICULAR DYSFUNCTION, LEFT;

EID: 10744229887     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejheart.2003.10.004     Document Type: Article

References (24)

1. Cohn J.N., Levine T.B., Olivari M.T., et al. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. New Engl J Med. 311:1984;819-823.
2. Packer M. Neurohormonal interactions and adaptations in congestive heart failure. Circulation. 77:1988;721-729.
3. Tsutamoto T., Wada A., Maeda K., et al. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction. Circulation. 96:1997;509-516.
4. Levine B., Kalman J., Mayer L., Howard M., Fillit H.M., Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. New Engl J Med. 323:1990;236-241.
5. Mann D.L., Young J.B. Basic mechanisms in congestive heart failure: recognizing the role of proinflammatory cytokines. Chest. 105:1994;897-904.
6. Torre-Amione G., Kapadia S., Lee J., et al. Tumor necrosis factor-α and tumor necrosis factor receptors in the failing human heart. Circulation. 93:1996;704-711.
7. Habib F.M., Springall D.R., Davies G.J., et al. Tumor necrosis factor and inducible nitric oxide synthase in dilated cardiomyopathy. Lancet. 347:1996;1151-1155.
8. Torre-Amione G., Stetson S.J., Youker K.A., et al. Decreased expression of tumor necrosis factor-α in failing human myocardium after mechanical circulatory support: a potential mechanism for cardiac recovery. Circulation. 100:1999;1189-1193.
9. Satoh M., Nakamura M., Saitoh H., et al. Tumor necrosis factor-α converting enzyme and tumor necrosis factor-α in human dilated cardiomyopathy. Circulation. 99:1999;3260-3265.
10. Kubota T., Miyagishima M., Alvarez, et al. Expression of proinflammatory cytokines in the failing human heart: comparison of recent-onset and end-staged congestive heart failure. J Heart Lung Transplant. 19:2000;819-824.
11. Birks E.J., Latif N., Owen V., et al. Quantitative myocardial cytokine expression and activation of the apoptotic pathway in patients who require left ventricular assist devices. Circulation. 104:2001;I-233-I-240.
12. Kubota T., McTierman C.F., Frye C.S., et al. Dilated cardiomyopathy in transgenic mice with cardiac-specific overexpression of tumor necrosis factor-α Circ Res. 81:1997;627-635.
13. Bryant D., Becker L., Richardson J., et al. Cardiac failure in transgenic mice with myocardial expression of tumor necrosis factor-α Circulation. 97:1998;1375-1381.
14. Munger M.A., Johnson B., Amber I.J., et al. Circulating concentrations of proinflammatory cytokines in mild or moderate heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol. 77:1996;723-727.
15. Wiedermann C.J., Beimpold H., Herold M., Knapp E., Braunsteiner H. Increased levels of serum neopterin and decreased production of neutrophil superoxide anions in chronic heart failure with elevated levels of tumor necrosis factor-α J Am Coll Cardiol. 22:1993;1897-1901.
16. Torre-Amione G., Kapadia S., Benedict C., Oral H., Young J.B., Mann D.L. Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the studies of left ventricular dysfunction (SOLVD). J Am Coll Cardiol. 27:1996;1201-1206.
17. Tsutamoto T., Hisanaga T., Wada A., et al. Interleukin-6 spillover in the peripheral circulation increases with the severity of heart failure, and the high plasma level of interleukin-6 is an important prognostic predictor in patients with congestive heart failure. J Am Coll Cardiol. 31:1998;391-398.
18. Maeda K., Tsutamoto T., Wada A., et al. High levels of plasma brain natriuretic peptide and interleukin-6 after optimized treatment for heart failure are independent risk factors for morbidity and mortality in patients with congestive heart failure. J Am Coll Cardiol. 36:2000;1587-1593.
19. Jirik F.R., Podor T.J., Hirano T. Bacterial lipopolysaccharide and inflammatory mediators augment IL-6 production secretion by human endothelial cells. J Immunol. 142:1989;144-147.
20. Lippnow H., Libby P. Proliferating or interleukin 1-activated human vascular smooth muscle cells secrete copious interleukin 6. J Clin Invest. 85:1990;731-738.
21. Mabuchi N., Tsutamoto T., Wada A., et al. Relationship between interleukin-6 spillover in the lungs and pulmonary vascular resistance in patients with congestive heart failure. Chest. 121:2002;1195-1202.
22. Yamaguchi-Takihara K., Ihara Y., Ogata A., et al. Hypoxic stress induces cardiac myocyte-derived interleukin-6. Circulation. 91:1995;180-185.
23. Plenz G., Eschert H., Erren M., et al. The interleukin-6/interleukin-6- receptorsystem is activated in donor hearts. J Am Coll Cardiol. 39:2002;1508-1512.
24. Tsutamoto T., Wada A., Matsumoto T., et al. Relationship between tumor necrosis factor-α production and oxidative stress in the failing heart of patients with dilated cardiomyopathy. J Am Coll Cardiol. 37:2001;2086-2092.